[HTML][HTML] Sjögren's syndrome: a systemic autoimmune disease

S Negrini, G Emmi, M Greco, M Borro… - Clinical and …, 2022 - Springer
Sjögren's syndrome is a chronic autoimmune disease characterized by ocular and oral
dryness resulting from lacrimal and salivary gland dysfunction. Besides, a variety of systemic …

Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment

FB Vivino, VY Bunya… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment …

Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure

S Arends, L de Wolff, JF van Nimwegen… - The Lancet …, 2021 - thelancet.com
Background Recent randomised controlled trials (RCTs) in primary Sjögren's syndrome
used the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease …

[HTML][HTML] Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)

E Gremese, B Tolusso, MR Gigante… - Frontiers in …, 2014 - frontiersin.org
The growing body of evidence recognizing the adipose tissue (AT) as an active endocrine
organ secreting bioactive mediators involved in metabolic and inflammatory disorders …

Primary Sjögren's syndrome

M Rischmueller, J Tieu, S Lester - Best practice & research Clinical …, 2016 - Elsevier
Primary Sjögren's syndrome (pSS) is a relatively common autoimmune systemic rheumatic
disease. In addition to sicca syndrome and swollen salivary glands, systemic features …

[HTML][HTML] Macrophages in renal injury, repair, fibrosis following acute kidney injury and targeted therapy

H Chen, N Liu, S Zhuang - Frontiers in immunology, 2022 - frontiersin.org
Acute kidney injury (AKI) is a renal disease with a high incidence and mortality. Currently,
there are no targeted therapeutics for preventing and treating AKI. Macrophages, important …

Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary …

R Seror, G Baron, M Camus, D Cornec… - Annals of the …, 2022 - ard.bmj.com
Objective To develop a composite responder index in primary Sjögren's syndrome (pSS):
the Sjögren's Tool for Assessing Response (STAR). Methods To develop STAR, the …

[HTML][HTML] Anxiety and depression in primary Sjögren's syndrome: a cross-sectional study

Y Cui, L Xia, L Li, Q Zhao, S Chen, Z Gu - BMC psychiatry, 2018 - Springer
Background Prevalence of anxiety and depression is high in people with Primary Sjögren's
syndrome (pSS). However, there are currently no known reported studies about …

Equal rights in autoimmunity: is Sjögren's syndrome ever 'secondary'?

F Kollert, BA Fisher - Rheumatology, 2020 - academic.oup.com
Sjögren's syndrome (SjS) accompanied by other systemic autoimmune rheumatic
connective tissue diseases has historically been termed 'secondary'in contrast to …

Severe Health‐Related quality of life impairment in active primary Sjögren's syndrome and Patient‐Reported outcomes: data from a large therapeutic trial

D Cornec, V Devauchelle‐Pensec… - Arthritis Care & …, 2017 - Wiley Online Library
Objective To identify the principal determinants of health‐related quality of life (HRQOL)
impairment in patients with active primary Sjögren's syndrome (SS) participating in a large …